全文获取类型
收费全文 | 16273篇 |
免费 | 537篇 |
国内免费 | 39篇 |
专业分类
16849篇 |
出版年
2023年 | 55篇 |
2022年 | 189篇 |
2021年 | 375篇 |
2020年 | 201篇 |
2019年 | 317篇 |
2018年 | 476篇 |
2017年 | 463篇 |
2016年 | 806篇 |
2015年 | 1098篇 |
2014年 | 1005篇 |
2013年 | 1601篇 |
2012年 | 1193篇 |
2011年 | 1025篇 |
2010年 | 1088篇 |
2009年 | 873篇 |
2008年 | 917篇 |
2007年 | 863篇 |
2006年 | 867篇 |
2005年 | 664篇 |
2004年 | 480篇 |
2003年 | 384篇 |
2002年 | 352篇 |
2001年 | 109篇 |
2000年 | 196篇 |
1999年 | 130篇 |
1998年 | 127篇 |
1997年 | 131篇 |
1996年 | 86篇 |
1995年 | 47篇 |
1994年 | 50篇 |
1993年 | 43篇 |
1992年 | 50篇 |
1991年 | 41篇 |
1990年 | 28篇 |
1989年 | 36篇 |
1988年 | 28篇 |
1987年 | 30篇 |
1986年 | 25篇 |
1985年 | 34篇 |
1984年 | 33篇 |
1983年 | 27篇 |
1982年 | 42篇 |
1981年 | 34篇 |
1980年 | 35篇 |
1979年 | 21篇 |
1977年 | 16篇 |
1976年 | 16篇 |
1975年 | 14篇 |
1974年 | 12篇 |
1973年 | 22篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Mario Campone Isabelle Valo Pascal Jézéquel Marie Moreau Alice Boissard Loic Campion Delphine Loussouarn Véronique Verriele Olivier Coqueret Catherine Guette 《Molecular & cellular proteomics : MCP》2015,14(11):2936-2946
To date, there is no available targeted therapy for patients who are diagnosed with triple-negative breast cancers (TNBC). The aim of this study was to identify a new specific target for specific treatments. Frozen primary tumors were collected from 83 adjuvant therapy-naive TNBC patients. These samples were used for global proteome profiling by iTRAQ-OFFGEL-LC-MS/MS approach in two series: a training cohort (n = 42) and a test set (n = 41). Patients who remains free of local or distant metastasis for a minimum of 5 years after surgery were classified in the no-relapse group; the others were in the relapse group. OPLS and Kaplan–Meier analyses were performed to select candidate markers, which were validated by immunohistochemistry. Three proteins were identified in the training set and validated in the test set by Kaplan–Meier method and immunohistochemistry (IHC): TrpRS as a good prognostic markers and DP and TSP1 as bad prognostic markers. We propose the establishment of an IHC test to calculate the score of TrpRS, DP, and TSP1 in TNBC tumors to evaluate the degree of aggressiveness of the tumors. Finally, we propose that DP and TSP1 could provide therapeutic targets for specific treatments.Triple-negative breast cancers (TNBC)1 are defined by a lack of expression of estrogen (ER), progesterone (PR), and HER2/neu receptors and account for about 15% of all breast cancers. This subtype is associated with poor prognosis (1) in terms of distant free survival (DFS) and overall survival (OS), and to date, there is no clinically available targeted therapy for patients diagnosed with TNBC. Because of the absence of specific treatment guidelines for this group of patients, TNBC are managed with standard adjuvant chemotherapy (2), which, however, seems to be less effective in those cancers. In order to improve survival, it is important to determine new specific-targeted treatment.A proteomic analysis has several inherent advantages over a genomic approach in that measured mRNA levels do not necessarily correlate to corresponding protein levels. In addition, protein detection is probably also more reflective of the tumor microenvironment. Several proteomic studies have been conducted on TNBC (3–5), but no proteomic study was conducted on large cohorts including the clinical outcome of the patients, except a recent comparative proteome analysis that identified a 11-protein signature for aggressive TNBC in a large cohort of 93 microdissected tumors (6). Although microdissection was necessary to elucidate the contribution of TNBC cells, it did not reflect the tumor with its microenvironment that is increasingly described as fundamental to explain the tumor outcome. Thus, it is now recognized that carcinomas derive from phenomena that occur in tissues, not in individual cancer cells. From this perspective, the microenvironment becomes an integral, essential part of the tumor (7, 8). In this context, taking into account the tumor microenvironment, we investigated a cohort of 83 TNBC samples without microdissection by a quantitative proteomic approach using iTRAQ labeling. Based on clinical data, we established a protein signature of the most aggressive tumors. From these differentially expressed proteins, some of them appeared to be potential therapeutic targets. 相似文献
992.
Barbara Salani Silvia Ravera Adriana Amaro Annalisa Salis Mario Passalacqua Enrico Millo Gianluca Damonte Cecilia Marini Ulrich Pfeffer Gianmario Sambuceti Renzo Cordera Davide Maggi 《Cell cycle (Georgetown, Tex.)》2015,14(10):1559-1567
Pyruvate kinase M2 (PKM2) acts at the crossroad of growth and metabolism pathways in cells. PKM2 regulation by growth factors can redirect glycolytic intermediates into key biosynthetic pathway. Here we show that IGF1 can regulate glycolysis rate, stimulate PKM2 Ser/Thr phosphorylation and decrease cellular pyruvate kinase activity. Upon IGF1 treatment we found an increase of the dimeric form of PKM2 and the enrichment of PKM2 in the nucleus. This effect was associated to a reduction of pyruvate kinase enzymatic activity and was reversed using metformin, which decreases Akt phosphorylation. IGF1 induced an increased nuclear localization of PKM2 and STAT3, which correlated with an increased HIF1α, HK2, and GLUT1 expression and glucose entrapment. Metformin inhibited HK2, GLUT1, HIF-1α expression and glucose consumption. These findings suggest a role of IGFIR/Akt axis in regulating glycolysis by Ser/Thr PKM2 phosphorylation in cancer cells. 相似文献
993.
994.
Yan Liu Kathleen DeBoer David M. de Kretser Liza O’Donnell Anne E. O’Connor D. Jo Merriner Hidenobu Okuda Belinda Whittle David A. Jans Athina Efthymiadis Robert I. McLachlan Christopher J. Ormandy Chris C. Goodnow Duangporn Jamsai Moira K. O’Bryan 《PLoS genetics》2015,11(3)
Male infertility affects at least 5% of reproductive age males. The most common pathology is a complex presentation of decreased sperm output and abnormal sperm shape and motility referred to as oligoasthenoteratospermia (OAT). For the majority of OAT men a precise diagnosis cannot be provided. Here we demonstrate that leucine-rich repeats and guanylate kinase-domain containing isoform 1 (LRGUK-1) is required for multiple aspects of sperm assembly, including acrosome attachment, sperm head shaping and the initiation of the axoneme growth to form the core of the sperm tail. Specifically, LRGUK-1 is required for basal body attachment to the plasma membrane, the appropriate formation of the sub-distal appendages, the extension of axoneme microtubules and for microtubule movement and organisation within the manchette. Manchette dysfunction leads to abnormal sperm head shaping. Several of these functions may be achieved in association with the LRGUK-1 binding partner HOOK2. Collectively, these data establish LRGUK-1 as a major determinant of microtubule structure within the male germ line. 相似文献
995.
996.
997.
998.
999.
Verbascoside down‐regulates some pro‐inflammatory signal transduction pathways by increasing the activity of tyrosine phosphatase SHP‐1 in the U937 cell line 下载免费PDF全文
Mirko Pesce Sara Franceschelli Alessio Ferrone Maria Anna De Lutiis Antonia Patruno Alfredo Grilli Mario Felaco Lorenza Speranza 《Journal of cellular and molecular medicine》2015,19(7):1548-1556
Polyphenols are the major components of many traditional herbal remedies, which exhibit several beneficial effects including anti‐inflammation and antioxidant properties. Src homology region 2 domain‐containing phosphatase‐1 (SHP‐1) is a redox sensitive protein tyrosine phosphatase that negatively influences downstream signalling molecules, such as mitogen‐activated protein kinases, thereby inhibiting inflammatory signalling induced by lipopolysaccharide (LPS). Because a role of transforming growth factor β‐activated kinase‐1 (TAK1) in the upstream regulation of JNK molecule has been well demonstrated, we conjectured that SHP‐1 could mediate the anti‐inflammatory effect of verbascoside through the regulation of TAK‐1/JNK/AP‐1 signalling in the U937 cell line. Our results demonstrate that verbascoside increased the phosphorylation of SHP‐1, by attenuating the activation of TAK‐1/JNK/AP‐1 signalling. This leads to a reduction in the expression and activity of both COX and NOS. Moreover, SHP‐1 depletion deletes verbascoside inhibitory effects on pro‐inflammatory molecules induced by LPS. Our data confirm that SHP‐1 plays a critical role in restoring the physiological mechanisms of inducible proteins such as COX2 and iNOS, and that the down‐regulation of TAK‐1/JNK/AP‐1 signalling by targeting SHP‐1 should be considered as a new therapeutic strategy for the treatment of inflammatory diseases. 相似文献